跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-AMOXI CAPSULE 250 MG - HSA Drug Approval Details
Approvals
/
HSA
/
APO-AMOXI CAPSULE 250 MG
Approved
THERAPEUTIC
APO-AMOXI CAPSULE 250 MG
APO-BIOTICS LIMITED (CANADA)
🇸🇬 Health Sciences Authority
Approval Date
Apr 5, 1988
Approval ID
802fe1c548fe3c0b
Company
APO-BIOTICS LIMITED (CANADA)
Type
Therapeutic
Approval Details
Approval Id
802fe1c548fe3c0b
Drug Name
APO-AMOXI CAPSULE 250 MG
Product Name
APO-AMOXI CAPSULE 250 MG
Approval Number
SIN00213P
Approval Date
1988-04-05
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
CAPSULE
Route Of Administration
ORAL
Atc Code
J01CA04
Atc Item Name
amoxicillin
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Company Detail Path
/organization/pharmaforte-singapore-pte-ltd
Active Ingredients
AMOXYCILLIN TRIHYDRATE EQV AMOXYCILLIN
250 mg
AMOXYCILLIN TRIHYDRATE EQV AMOXYCILLIN
250 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Apr 5, 1988
Approval ID
802fe1c548fe3c0b
Type
Therapeutic
Back to HSA Approvals